These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28694265)

  • 1. Medication-Assisted Treatment Should Be Part of Every Family Physician's Practice: No.
    Hill RR
    Ann Fam Med; 2017 Jul; 15(4):310-312. PubMed ID: 28694265
    [No Abstract]   [Full Text] [Related]  

  • 2. Medication-Assisted Treatment Should Be Part of Every Family Physician's Practice: Yes.
    Loxterkamp D
    Ann Fam Med; 2017 Jul; 15(4):309-310. PubMed ID: 28694264
    [No Abstract]   [Full Text] [Related]  

  • 3. A Nurse Practitioner's Perspective on Prescribing Suboxone for Opioid Use Disorder.
    Moore DJ
    J Addict Nurs; 2018; 29(3):226-229. PubMed ID: 30180012
    [No Abstract]   [Full Text] [Related]  

  • 4. Rural Opioid Use Disorder Treatment Depends on Family Physicians.
    Wingrove P; Park B; Bazemore A
    Am Fam Physician; 2016 Oct; 94(7):546. PubMed ID: 27929214
    [No Abstract]   [Full Text] [Related]  

  • 5. Medication-Assisted Treatment of Opioid Use Disorder in Adolescents and Young Adults.
    Cottrill CB; Matson SC
    Adolesc Med State Art Rev; 2014 Aug; 25(2):251-65. PubMed ID: 27132312
    [No Abstract]   [Full Text] [Related]  

  • 6. The Shelby Clinic Medication-Assisted Treatment for Opioid Addiction.
    Penn CL
    J Ark Med Soc; 2016 Aug; 113(2):30-32. PubMed ID: 30047628
    [No Abstract]   [Full Text] [Related]  

  • 7. Geographic and specialty distribution of US physicians trained to treat opioid use disorder.
    Rosenblatt RA; Andrilla CH; Catlin M; Larson EH
    Ann Fam Med; 2015; 13(1):23-6. PubMed ID: 25583888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buprenorphine-Naloxone Treatment in Physicians and Nurses With Opioid Dependence.
    Braquehais MD; Fadeuilhe C; Håkansson A; Bel MJ; Navarro MC; Roncero C; Bruguera E; Casas M
    Subst Abus; 2015; 36(2):138-40. PubMed ID: 25738533
    [No Abstract]   [Full Text] [Related]  

  • 9. A New Formulation of Buprenorphine/Naloxone.
    J Addict Nurs; 2015; 26(2):104-5. PubMed ID: 26053085
    [No Abstract]   [Full Text] [Related]  

  • 10. Physician-pharmacist collaborative care model for buprenorphine-maintained opioid-dependent patients.
    DiPaula BA; Menachery E
    J Am Pharm Assoc (2003); 2015; 55(2):187-92. PubMed ID: 25749264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How Family Physicians Can Combat the Opioid Epidemic.
    Middleton JL
    Am Fam Physician; 2017 Sep; 96(6):357-358. PubMed ID: 28925644
    [No Abstract]   [Full Text] [Related]  

  • 12. Analysis of barriers to adoption of buprenorphine maintenance therapy by family physicians.
    DeFlavio JR; Rolin SA; Nordstrom BR; Kazal LA
    Rural Remote Health; 2015; 15():3019. PubMed ID: 25651434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary care management of opioid use disorders: Abstinence, methadone, or buprenorphine-naloxone?
    Srivastava A; Kahan M; Nader M
    Can Fam Physician; 2017 Mar; 63(3):200-205. PubMed ID: 28292795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Opioid Agonist Therapy for Medicare Patients in 2013.
    Lembke A; Chen JH
    JAMA Psychiatry; 2016 Sep; 73(9):990-2. PubMed ID: 27438334
    [No Abstract]   [Full Text] [Related]  

  • 15. Interim buprenorphine treatment in opiate dependence: A pilot effectiveness study.
    Abrahamsson T; Widinghoff C; Lilliebladh A; Gedeon C; Nilvall K; Hakansson A
    Subst Abus; 2016; 37(1):104-9. PubMed ID: 26176490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication-Assisted Treatment for Opioid Use Disorder in Older Adults: An Emerging Role for the Geriatric Psychiatrist.
    Joshi P; Shah NK; Kirane HD
    Am J Geriatr Psychiatry; 2019 Apr; 27(4):455-457. PubMed ID: 30718033
    [No Abstract]   [Full Text] [Related]  

  • 17. Barriers Rural Physicians Face Prescribing Buprenorphine for Opioid Use Disorder.
    Andrilla CHA; Coulthard C; Larson EH
    Ann Fam Med; 2017 Jul; 15(4):359-362. PubMed ID: 28694273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reimbursement and practice policies among providers of buprenorphine-naloxone treatment.
    Wisniewski AM; Dlugosz MR; Blondell RD
    Subst Abus; 2013; 34(2):105-7. PubMed ID: 23577902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helping 'them': our role in recovery from opioid dependence.
    Loxterkamp D
    Ann Fam Med; 2006; 4(2):168-71. PubMed ID: 16569721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A buprenorphine-naloxone induction in the North.
    Jones MK; Quinn M
    Can J Rural Med; 2021; 26(1):35-37. PubMed ID: 33380605
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.